INMD: Hold, Guidance, AI Insights
Hello! Today, I've brought this topic to you! We're diving into the latest financial buzz around InMode Ltd. (NASDAQ:INMD) , a prominent player in the aesthetic medical device industry. If you've been following the market, you know that keeping an eye on expert ratings and company guidance is crucial for making informed decisions. So, let's unpack the recent report from Canaccord Genuity and InMode's updated outlook, along with some broader market insights! ☆ Topic 1: Canaccord Genuity Weighs In: A 'Hold' Rating for INMD Financial analysts often provide key insights that can guide our investment decisions, offering a professional perspective on a company's prospects. Recently, Caitlin Cronin from Canaccord Genuity released a report on InMode Ltd. (NASDAQ:INMD). On July 10, 2025 , she maintained a Hold rating on the stock, setting a price target of $15.00 . This means that while Canaccord Genuity sees potential in InMode, they don't anti...